HIGHLIGHTS
- who: Eduardo I. Cardenas from the University of Patras, Greece have published the article: Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19, in the Journal: (JOURNAL)
- what: All data on IL-26, as well as all comparisons presented in this study have not been published elsewhere.
SUMMARY
Messenger RNA vaccines encoding for the SARS-CoV-2 spike_protein have proven effective at reducing the number of severe cases of COVID-19. The authors have previously shown that IL-26 acts via its receptor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.